The GLP-1 analogue lixisenatide decreases atherosclerosis in insulin-resistant mice by modulating macrophage phenotype
Crossref DOI link: https://doi.org/10.1007/s00125-017-4330-3
Published Online: 2017-06-12
Published Print: 2017-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Vinué, Ángela
Navarro, Jorge
Herrero-Cervera, Andrea
García-Cubas, Marta
Andrés-Blasco, Irene
Martínez-Hervás, Sergio
Real, José T.
Ascaso, Juan F.
González-Navarro, Herminia
License valid from 2017-06-12